Birchview Capital, LP’s Albireo Pharma Inc Position
Does Birchview Capital, LP own Albireo Pharma Inc (BDQM)? Not currently — the last reported position was 117.0K shares worth $2,528 in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2,528
Q4 2022
Shares
117.0K
% of Portfolio
+1.79%
Quarters Held
17
position exited
Position History BDQM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 117.0K | $2,528 | +1.79% |
| Q3 2022 | 117.0K | $2M | +1.59% |
| Q2 2022 | 113.0K | $2M | +1.63% |
| Q1 2022 | 113.0K | $3M | +2.43% |
| Q4 2021 | 113.0K | $3M | +1.70% |
| Q3 2021 | 113.0K | $4M | +2.40% |
| Q2 2021 | 111.0K | $4M | +2.34% |
| Q1 2021 | 111.0K | $4M | +2.32% |
| Q4 2020 | 92.0K | $3M | +1.99% |
| Q3 2020 | 58.0K | $2M | +1.29% |
| Q2 2020 | 48.0K | $1M | +0.77% |
| Q1 2020 | 48.0K | $786,000 | +0.70% |
| Q4 2019 | 48.0K | $1M | +0.89% |
| Q3 2019 | 38.0K | $760,000 | +0.51% |
| Q2 2019 | 38.0K | $1M | +0.75% |
| Q1 2019 | 38.0K | $1M | +0.77% |
| Q4 2018 | 38.0K | $932,000 | +0.88% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of BDQM.